Introduction: a fresh look at monoamine oxidase inhibitors for depression

J Clin Psychiatry. 2012:73 Suppl 1:3-4. doi: 10.4088/JCP.11096su1c.00.

Authors

Lawrence J Cohen¹, David A Sclar

Affiliation

¹ Department of Pharmacotherapy, Washington State University College of Pharmacy, Spokane, USA. lawrence-cohen@att.net

PMID: 22951235
DOI: 10.4088/JCP.11096su1c.00

No abstract available

Publication types

Introductory Journal Article

MeSH terms

Antidepressive Agents / adverse effects
Antidepressive Agents / therapeutic use*
Depressive Disorder / classification
Depressive Disorder / drug therapy*
Depressive Disorder / psychology
Depressive Disorder, Treatment-Resistant / classification
Depressive Disorder, Treatment-Resistant / drug therapy
Depressive Disorder, Treatment-Resistant / psychology
Humans
Monoamine Oxidase Inhibitors / adverse effects
Monoamine Oxidase Inhibitors / therapeutic use*
Treatment Outcome

Substances

Antidepressive Agents
Monoamine Oxidase Inhibitors